How is high-risk smoldering multiple myeloma diagnosed?
In this video, Dr. Brian G.M. Durie explains that active myeloma is diagnosed if a patient has CRAB features and myeloma-defining events. He also sheds light on a new set of criteria for high-risk smoldering multiple myeloma, known as the 2/20/20 rule.
If you have a question that you’d like to suggest for a future episode of Ask Dr. Durie, please submit it to [email protected].
To reach the IMF InfoLine Coordinators, please call 800.452.2873 or email them at [email protected].
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.